ScholarIQanswers from OpenAlex

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

PaperCitations, authors & open-access status

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database have?

ScholarIQcitation count

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database has 50 citations in the OpenAlex counts ScholarIQ stores.

When was Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database published?

ScholarIQyear

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database has 2018 year in the ScholarIQ index.

What is the open-access status of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database?

ScholarIQoa status

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database has gold oa status in the ScholarIQ index.

What is the DOI of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database?

ScholarIQdoi

The DOI for Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database is on the source record.

What is the PMID of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database?

ScholarIQpmid

The PMID for Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database is on the source record.

What is the OpenAlex record for Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database?

ScholarIQopenalex

The OpenAlex for Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial